India has also had its fair share of tragedies due to “poisonous”, sub-standard or spurious formulations. Hence, quality control needs to be stringent, with criminal and financial liability on the perpetrators, industry experts told TOI. “The Centre and state government need to come down heavily and swiftly on Maiden Pharmaceuticals. India — the pharmacy of the world with one-third of the global share in drugs (by volume) — cannot afford such tragedies,” a top official with a company said.